Research Peptides
Retatrutide
Triple GIP/GLP-1/glucagon receptor analogue for comparative receptor research.
Retatrutide is a synthetic triple agonist analogue acting at the GIP, GLP-1 and glucagon receptors. It is supplied for in-vitro receptor pharmacology and metabolic-signalling research.
Select a size
Line total
$125.00
Dispatched cold in insulated packaging within 48 hours.
Specifications
- Purity
- ≥98% (HPLC)
- Form
- Lyophilized powder
- Sequence
- Available on request
- Molecular weight
- 4731.33 Da
- CAS number
- 2381089-83-2
- Storage
- Store at -20°C, protected from light
Specifications are listed for reference. Always confirm against the certificate of analysis supplied with your lot.
Research use only
This material is supplied for in-vitro laboratory research and analytical study only. It is not for human or veterinary use, not a medicine, supplement or cosmetic, and must never be ingested, injected or applied to any living organism. Purchasers must be 21 or over and qualified to handle research chemicals safely.
Research & literature
What published research reports
The following summarises peer-reviewed literature for scientific reference only. AethelBio products are supplied strictly for in-vitro laboratory research and are not intended for human or veterinary use, diagnosis, prevention, or treatment of any condition.
Proposed mechanism
A triple agonist of the GIP, GLP-1, and glucagon receptors, combining insulinotropic and appetite-suppressing activity with glucagon-mediated effects on energy expenditure.
Reported areas of research
Published early- and late-phase trials report substantial weight reduction and improved glycaemic control; ongoing research examines cardiometabolic and hepatic outcomes.
PubMed references
Verified buyer reviews
What researchers say
No reviews yet — be the first to share your results.